Assessing the Future of Solid Tumor Immunotherapy
With the advent of cancer immunotherapy, there has been a major improvement in patient’s quality of life and survival. The growth of cancer immunotherapy has dramatically changed our understanding of the basics of cancer biology and has altered the standards of care (surgery, radiotherapy, and chemo...
Main Authors: | Prajna Guha, Kara R. Heatherton, Kyle P. O’Connell, Ian S. Alexander, Steven C. Katz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/3/655 |
Similar Items
-
New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01) -
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for Glioblastoma
by: Kristen D. Pawlowski, et al.
Published: (2023-12-01) -
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy
by: Massimo Fantini, et al.
Published: (2023-11-01) -
Modern T cell technologies for immunotherapy of solid tumors
by: M. S. Kuznetsova, et al.
Published: (2023-04-01) -
The role of MSCs and CAR-MSCs in cellular immunotherapy
by: Lun Yan, et al.
Published: (2023-08-01)